Sachin Kulkarni took a good look at his life when he turned 40 and decided to get a checkup. After that, everything changed ...

Research shows that millions of people are not up to date with colorectal cancer screening recommendations. Exact aims to ...

SOLARIS (Alliance A021703), a multicenter, double-blind, randomized Phase III clinical trial led by Dana-Farber Cancer ...

A potential benefit for high-dose vitamin D3 was observed for patients with left-sided disease (i.e., primary tumors that ...

Taking race into account when developing tools to predict a patient's risk of colorectal cancer leads to more accurate predictions when compared with ...

Rates of colorectal cancer are increasing among young people—and most Americans are only getting about half their daily ...

Treatment with Cyramza plus Lonsurf did not improve overall survival compared with Lonsurf alone in heavily pretreated ...

NuCana plc (NASDAQ:NCNA) presented final data from the Phase 2 NuTide:701 study at the ESMO Congress on NUC-7738 in ...

The combination of ramucirumab with trifluridine/tipiracil failed to show improvements in overall survival vs TAS-102 alone ...

Researchers investigated the efficacy of total neoadjuvant treatment followed by nonoperative management in patients with locally advanced rectal cancer.

Hanke underscored that changes in the money supply, not interest rates, are the primary drivers of economic trends. He expressed confidence in gold's continued strength and advised investors to reduce ...

A double-blind randomized phase 3 clinical trial led by Dana-Farber Cancer Institute researchers and conducted across several ...